BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34681590)

  • 1. TMEM16A, a Homoharringtonine Receptor, as a Potential Endogenic Target for Lung Cancer Treatment.
    Guo S; Bai X; Shi S; Deng Y; Kang X; An H
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrine is a novel inhibitor of the TMEM16A chloride channel with antilung adenocarcinoma effects.
    Guo S; Chen Y; Pang C; Wang X; Shi S; Zhang H; An H; Zhan Y
    J Cell Physiol; 2019 Jun; 234(6):8698-8708. PubMed ID: 30370542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homoharringtonine suppresses LoVo cell growth by inhibiting EphB4 and the PI3K/AKT and MAPK/EKR1/2 signaling pathways.
    Shi X; Zhu M; Gong Z; Yang T; Yu R; Wang J; Zhang Y
    Food Chem Toxicol; 2020 Feb; 136():110960. PubMed ID: 31726078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arctigenin, a novel TMEM16A inhibitor for lung adenocarcinoma therapy.
    Guo S; Chen Y; Shi S; Wang X; Zhang H; Zhan Y; An H
    Pharmacol Res; 2020 May; 155():104721. PubMed ID: 32097750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of TMEM16A Ca
    Zhang X; Zhang G; Zhai W; Zhao Z; Wang S; Yi J
    Pharmacol Res; 2020 Jun; 156():104763. PubMed ID: 32201246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncovering the action mechanism of homoharringtonine against colorectal cancer by using network pharmacology and experimental evaluation.
    Qu M; Li J; Yuan L
    Bioengineered; 2021 Dec; 12(2):12940-12953. PubMed ID: 34847838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theaflavin binds to a druggable pocket of TMEM16A channel and inhibits lung adenocarcinoma cell viability.
    Shi S; Ma B; Sun F; Qu C; An H
    J Biol Chem; 2021 Sep; 297(3):101016. PubMed ID: 34329684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homoharringtonine Exerts an Antimyeloma Effect by Promoting Excess Parkin-Dependent Mitophagy.
    Zhang Y; Huang N; Xu J; Zheng W; Cui X
    Drug Des Devel Ther; 2020; 14():4749-4763. PubMed ID: 33177810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TMEM16A as a Potential Biomarker in the Diagnosis and Prognosis of Lung Cancer.
    Hu C; Zhang R; Jiang D
    Arch Iran Med; 2019 Jan; 22(1):32-38. PubMed ID: 30821158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homoharringtonine stabilizes secondary structure of guanine-rich sequence existing in the 5'-untranslated region of Nrf2.
    Kang JS; Lee J; Nam LB; Yoo OK; Pham KT; Duong TH; Keum YS
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2189-2196. PubMed ID: 31270017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zafirlukast inhibits the growth of lung adenocarcinoma via inhibiting TMEM16A channel activity.
    Shi S; Ma B; Sun F; Qu C; Li G; Shi D; Liu W; Zhang H; An H
    J Biol Chem; 2022 Mar; 298(3):101731. PubMed ID: 35176281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An anticancer agent-loaded PLGA nanomedicine with glutathione-response and targeted delivery for the treatment of lung cancer.
    Zhang Z; Cheng W; Pan Y; Jia L
    J Mater Chem B; 2020 Jan; 8(4):655-665. PubMed ID: 31904073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor Homoharringtonine.
    Howard TP; Oberlick EM; Rees MG; Arnoff TE; Pham MT; Brenan L; DoCarmo M; Hong AL; Kugener G; Chou HC; Drosos Y; Mathias KM; Ramos P; Seashore-Ludlow B; Giacomelli AO; Wang X; Freeman BB; Blankenship K; Hoffmann L; Tiv HL; Gokhale PC; Johannessen CM; Stewart EA; Schreiber SL; Hahn WC; Roberts CWM
    Clin Cancer Res; 2020 Sep; 26(18):4995-5006. PubMed ID: 32631955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cepharanthine, a novel selective ANO1 inhibitor with potential for lung adenocarcinoma therapy.
    Zhang X; Zhang G; Zhao Z; Xiu R; Jia J; Chen P; Liu Y; Wang Y; Yi J
    Biochim Biophys Acta Mol Cell Res; 2021 Nov; 1868(12):119132. PubMed ID: 34450215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homoharringtonine binds to and increases myosin-9 in myeloid leukaemia.
    Zhang T; Shen S; Zhu Z; Lu S; Yin X; Zheng J; Jin J
    Br J Pharmacol; 2016 Jan; 173(1):212-21. PubMed ID: 26448459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin in combination with homoharringtonine suppresses lymphoma cell growth by inhibiting the TGF-β/Smad3 signaling pathway.
    Zhang Y; Xiang J; Zhu N; Ge H; Sheng X; Deng S; Chen J; Yu L; Zhou Y; Shen J
    Aging (Albany NY); 2021 Jul; 13(14):18757-18768. PubMed ID: 34324434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzophenanthridine alkaloids suppress lung adenocarcinoma by blocking TMEM16A Ca
    Zhang G; Zhu L; Xue Y; Zhao Z; Li H; Niu Z; Wang X; Chen P; Zhang J; Zhang X
    Pflugers Arch; 2020 Oct; 472(10):1457-1467. PubMed ID: 32683500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homoharringtonine suppresses tumor proliferation and migration by regulating EphB4-mediated β-catenin loss in hepatocellular carcinoma.
    Zhu M; Gong Z; Wu Q; Su Q; Yang T; Yu R; Xu R; Zhang Y
    Cell Death Dis; 2020 Aug; 11(8):632. PubMed ID: 32801343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanism of ion channel protein TMEM16A regulated by natural product of narirutin for lung cancer adjuvant treatment.
    Shi S; Bai X; Ji Q; Wan H; An H; Kang X; Guo S
    Int J Biol Macromol; 2022 Dec; 223(Pt A):1145-1157. PubMed ID: 36400205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homoharringtonine promotes BCR‑ABL degradation through the p62‑mediated autophagy pathway.
    Li S; Bo Z; Jiang Y; Song X; Wang C; Tong Y
    Oncol Rep; 2020 Jan; 43(1):113-120. PubMed ID: 31789418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.